How should I interpret these arterial blood gas results (pH 7.61, PaCO₂ 16.4 mm Hg, HCO₃⁻ 16.7 mmol/L, PaO₂ 62.6 mm Hg on room air, SpO₂ 95.9%, lactate 1.8 mmol/L, anion gap ≈ 18) and what is the appropriate management?

Mixed Acid-Base Disorder: Respiratory Alkalosis with High Anion Gap Metabolic Acidosis

This patient has a mixed acid-base disorder consisting of primary respiratory alkalosis (marked hyperventilation with pH 7.61 and PaCO₂ 16.4 mmHg) combined with high anion gap metabolic acidosis (AG ~18, HCO₃⁻ 16.7 mmol/L), and requires immediate investigation for the underlying cause of hyperventilation while addressing hypoxemia.

Primary Interpretation

The marked alkalemia (pH 7.61) with severe hypocapnia (PaCO₂ 16.4 mmHg) indicates primary respiratory alkalosis from aggressive hyperventilation. However, the bicarbonate is inappropriately low (16.7 mmol/L) for pure respiratory alkalosis—expected compensation would only drop HCO₃⁻ by approximately 2-4 mmol/L for this degree of acute hypocapnia. The elevated anion gap (~18) confirms a concurrent high anion gap metabolic acidosis 1, 2.

Key Diagnostic Features:

• Respiratory alkalosis: pH 7.61 with PaCO₂ 16.4 mmHg indicates extreme hyperventilation
• Metabolic acidosis: HCO₃⁻ 16.7 mmol/L with AG ~18 (normal <12-14)
• Hypoxemia: PaO₂ 62.6 mmHg on room air (normal >80 mmHg) 3
• Normal lactate: 1.8 mmol/L excludes lactic acidosis as the primary cause

Immediate Management Priorities

1. Oxygen Therapy

Initiate supplemental oxygen immediately to target SpO₂ 94-98% given the PaO₂ of 62.6 mmHg 4, 3. Start with nasal cannulae at 2-4 L/min or simple face mask at 5-10 L/min, titrating to achieve target saturation 4. The 2017 BTS guidelines recommend oxygen therapy for PaO₂ <60 mmHg (8.0 kPa), and this patient is borderline at 62.6 mmHg 4.

2. Identify the Cause of High Anion Gap Metabolic Acidosis

With normal lactate, investigate for 1, 2, 5:

• Diabetic ketoacidosis (DKA): Check blood glucose, serum ketones (β-hydroxybutyrate preferred over nitroprusside method), and urinalysis. DKA diagnostic criteria include glucose >250 mg/dl, pH <7.3, and bicarbonate <15 mEq/L 1
• Toxic ingestions: Calculate osmolal gap to screen for methanol, ethylene glycol, or salicylates 2, 5
• Renal failure: Check BUN and creatinine (though typically causes hyperchloremic acidosis rather than high AG) 2
• Other ketoacidosis: Alcoholic or starvation ketoacidosis

3. Determine the Cause of Hyperventilation

The extreme respiratory alkalosis (pH 7.61, PaCO₂ 16.4) suggests 6:

• Hypoxemia-driven: The PaO₂ of 62.6 mmHg may be triggering compensatory hyperventilation—investigate for pneumonia, pulmonary embolism, acute respiratory distress syndrome, or pulmonary edema
• Pain or anxiety: Though less likely to produce this degree of alkalosis
• Sepsis: Can cause respiratory alkalosis even before metabolic acidosis develops 7
• Salicylate toxicity: Classic cause of mixed respiratory alkalosis and high AG metabolic acidosis (check salicylate level)
• Pregnancy: Physiologic hyperventilation but not to this extreme

Diagnostic Workup

Obtain immediately:

• Complete metabolic panel: Electrolytes, glucose, BUN, creatinine, calcium, phosphate
• Serum ketones: β-hydroxybutyrate measurement (not nitroprusside method which misses the predominant ketone) 1
• Serum osmolality: Calculate osmolal gap to screen for toxic alcohols 5
• Salicylate level: Given the classic mixed picture
• Lactate: Already normal at 1.8 mmol/L
• Chest radiograph: Evaluate for pneumonia, pulmonary edema, or other pulmonary pathology
• Urinalysis: Check for ketones and glucose
• Complete blood count: Assess for infection or anemia

Monitoring and Reassessment

• Repeat blood gases in 30-60 minutes after initiating oxygen therapy to assess response and ensure no worsening of acid-base status 4
• Continuous pulse oximetry monitoring 3
• Monitor for signs of respiratory muscle fatigue—this degree of hyperventilation is exhausting and the patient may decompensate
• Track vital signs closely, particularly respiratory rate (likely >25 breaths/min given PaCO₂ of 16.4)

Critical Clinical Pitfalls

Do not assume the respiratory alkalosis is "compensating" for metabolic acidosis—the pH of 7.61 proves the respiratory process is primary and excessive. In pure metabolic acidosis compensation, pH would remain acidemic or near-normal, not markedly alkalemic.

Do not withhold oxygen based on the SpO₂ of 95.9%—the PaO₂ of 62.6 mmHg indicates true hypoxemia that requires correction 3. The relatively preserved SpO₂ reflects the leftward shift of the oxygen-hemoglobin dissociation curve caused by alkalemia, which impairs oxygen delivery to tissues.

Consider intubation criteria early if the patient shows signs of respiratory muscle fatigue, altered mental status, or inability to maintain adequate ventilation. The 2016 ESC guidelines recommend intubation for respiratory failure with PaO₂ <60 mmHg, hypercapnia >50 mmHg, and acidosis pH <7.35 that cannot be managed non-invasively 3. While this patient is currently hypocapnic rather than hypercapnic, the extreme work of breathing may lead to decompensation.

Recheck blood gases frequently (every 30-60 minutes initially) as recommended for DKA management 1, or sooner if clinical deterioration occurs. Venous pH can be used for monitoring (typically 0.03 units lower than arterial) to reduce arterial punctures 1, 2.

Specific Treatment Based on Etiology

Once the underlying cause is identified:

• If DKA: Initiate insulin infusion (0.15 U/kg bolus, then 0.1 U/kg/h continuous infusion), aggressive fluid resuscitation with isotonic saline (15-20 ml/kg/h initially), and potassium replacement once K+ >3.3 mEq/L. Resolution criteria include glucose <200 mg/dl, bicarbonate ≥18 mEq/L, and venous pH >7.3 1, 2

• If toxic ingestion: Specific antidotes (fomepizole for toxic alcohols, sodium bicarbonate for salicylates) and consider hemodialysis

• If pulmonary pathology: Treat underlying pneumonia, pulmonary embolism, or heart failure as indicated. Consider non-invasive positive pressure ventilation if respiratory distress persists despite oxygen therapy 3, 8